Suchergebnisse - "Mitsudomi, Tetsuya"

PubPharm (583)

1

MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Haratake, N. | Ozawa, H. | Morimoto, Y. | +16

2

A case of late-onset bleeding from an intercostal artery pseudoaneurysm after hemostasis using soft coagulation

enthalten in: Surgical case reports | 2024

von Shimizu, R. | Suda, K. | Takemoto, T. | +6

3

NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC : translational research of phase III IMPACT study

enthalten in: Molecular oncology | 2024

von Ikeda, S. | Tsuboi, M. | Sakai, K. | +29

4

Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816

enthalten in: Cancer science | 2024

von Mitsudomi, T. | Ito, H. | Okada, M. | +16

5

ANTICANCER THERAPY

enthalten in: Europäisches Patentamt | 2024

von MITSUDOMI TETSUYA | KOGA TAKAMASA | HOFMANN MARCO HANS | +1

6

ANTICANCER THERAPY

enthalten in: Europäisches Patentamt | 2024

von MITSUDOMI TETSUYA | KOGA TAKAMASA | HOFMANN MARCO HANS | +1

7

Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Hamada, A. | Suda, K. | Nishino, M. | +14

CommentIn: J Thorac Oncol. 2024 Jan;19(1):10-12. - PMID 38185508

8

The International Association for the Study of Lung Cancer Early Lung Imaging Confederation Open-Source Deep Learning and Quantitative Measurement Initiative

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Lam, S. | Wynes, M. | Connolly, C. | +27

9

NOTCH1 and CREBBP co‐mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR‐mutated NSCLC : translational research of phase III IMPACT study

enthalten in: Molecular Oncology | 2024

von Ikeda, S. | Tsuboi, M. | Sakai, K. | +29

10

Five-Year Overall Survival Analysis of the JIPANG Study : Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non-Small-Cell Lung Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Kenmotsu, H. | Yamamoto, N. | Misumi, T. | +17

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[59]